Literature DB >> 18055928

Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosis.

Julia M Lappin1, Paola Dazzan, Kevin Morgan, Craig Morgan, Xavier Chitnis, John Suckling, Paul Fearon, Peter B Jones, Julian Leff, Robin M Murray, Philip K McGuire.   

Abstract

BACKGROUND: First-episode psychosis is typically preceded by a prodrome in which there is deterioration in global and social functioning. AIMS: To examine whether the duration of the prodromal phase influences grey and white matter volumes at the onset of psychosis.
METHODS: Eighty-two people were scanned using magnetic resonance imaging when they developed a first episode of psychosis. The duration of the prodromal phase was estimated from detailed interviews and medical records. Voxel-based morphometry was used to assess neuroanatomical abnormalities.
RESULTS: A long prodromal phase was associated with smaller grey matter volumes in the cingulate, frontal and left insular cortex, and with less white matter volume bilaterally in the superior longitudinal and uncinate fasciculi and the cingulum.
CONCLUSIONS: The severity of volumetric abnormalities in first-episode psychosis was greater in those with a long prodrome.

Entities:  

Mesh:

Year:  2007        PMID: 18055928     DOI: 10.1192/bjp.191.51.s123

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  11 in total

Review 1.  Research in people with psychosis risk syndrome: a review of the current evidence and future directions.

Authors:  Christoph U Correll; Marta Hauser; Andrea M Auther; Barbara A Cornblatt
Journal:  J Child Psychol Psychiatry       Date:  2010-02-26       Impact factor: 8.982

2.  Duration of the psychosis prodrome.

Authors:  Albert R Powers; Jean Addington; Diana O Perkins; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Daniel H Mathalon; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan; Scott W Woods
Journal:  Schizophr Res       Date:  2019-12-02       Impact factor: 4.939

3.  Gender difference in the prodromal symptoms of first-episode schizophrenia.

Authors:  Jung-Seok Choi; Myong-Wuk Chon; Do-Hyung Kang; Myung Hun Jung; Jun Soo Kwon
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

4.  Prodromal research: Public health initiatives for prevention of schizophrenia.

Authors:  Amresh Shrivastava
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

5.  In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia.

Authors:  George Bartzokis; Po H Lu; Stephanie B Stewart; Bolanle Oluwadara; Andrew J Lucas; Joanna Pantages; Erika Pratt; Jonathan E Sherin; Lori L Altshuler; Jim Mintz; Michael J Gitlin; Kenneth L Subotnik; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-17       Impact factor: 4.939

6.  Understanding pathophysiology is crucial in linking clinical staging to targeted therapeutics.

Authors:  Oliver D Howes; Philip K McGuire; Shitij Kapur
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

Review 7.  Investigation of Schizophrenia with Human Induced Pluripotent Stem Cells.

Authors:  Samuel K Powell; Callan P O'Shea; Sara Rose Shannon; Schahram Akbarian; Kristen J Brennand
Journal:  Adv Neurobiol       Date:  2020

Review 8.  Exploring predictors of outcome in the psychosis prodrome: implications for early identification and intervention.

Authors:  Tara A Niendam; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropsychol Rev       Date:  2009-07-14       Impact factor: 7.444

9.  Duration of untreated psychosis is associated with temporal and occipitotemporal gray matter volume decrease in treatment naïve schizophrenia.

Authors:  Xiaofeng Guo; Jun Li; Qinling Wei; Xiaoduo Fan; David N Kennedy; Yidong Shen; Huafu Chen; Jingping Zhao
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

10.  Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss.

Authors:  Gary Price; Mara Cercignani; Elvina M Chu; Thomas R E Barnes; Gareth J Barker; Eileen M Joyce; Maria A Ron
Journal:  Neuroimage       Date:  2009-07-23       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.